BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (SPI), an international pharmaceutical company, today announced that Greg Deener has joined Sucampo Pharma Americas, Inc. (SPA), its wholly-owned subsidiary, as Vice President of Marketing, Strategy & Implementation. He will be responsible for key marketing functions related to Sucampo’s approved drugs in addition to playing a key role in developing global marketing strategies for Sucampo’s pipeline compounds. He will report to Stanley G. Miele, Senior Vice President of Sales & Marketing of SPI and President of SPA.
